SCHEMBL23590308

SCHEMBL23590308

O=C(O)c1cc(-c2ccc(-c3cccc(F)c3)cc2)nc2ccc(C(F)(F)F)cc12

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 10/20 0.68
▸ ALDH1A1 P00352 3/20 0.55
▸ HSD17B10 Q99714 3/20 0.55
▸ HIF1A Q16665 2/20 0.55
▸ PTGES O14684 1/20 0.55
▸ ALOX5 P09917 1/20 0.55
▸ CYP2C9 P11712 1/20 0.55
▸ HPGD P15428 1/20 0.55
▸ CASP7 P55210 1/20 0.55
▸ GAA P10253 1/20 0.55
▸ MEN1 O00255 1/20 0.55
▸ KMT2A Q03164 1/20 0.55
▸ TP53 P04637 1/20 0.54
▸ CYP1A2 P05177 1/20 0.54
▸ CYP2C19 P33261 1/20 0.54
▸ KDM4E B2RXH2 2/20 0.51
▸ LMNA P02545 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ PDE10A Q9Y233 1/20 0.50
▸ EPRS1 P07814 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23590028 0.90 DHODH (0.62) DHODHALDH1A1HSD17B10HIF1APTGES
SCHEMBL23590031 0.88 DHODH (0.87) DHODHALDH1A1HSD17B10HIF1APTGES
SCHEMBL6181595 0.87 ALDH1A1 (0.59) DHODHALDH1A1HSD17B10HIF1APTGES
SCHEMBL23590326 0.86 DHODH (0.67) DHODHALDH1A1HSD17B10HIF1APTGES
SCHEMBL29617663 0.86 DHODH (0.67) DHODHALDH1A1HSD17B10HIF1APTGES
SCHEMBL23590309 0.83 DHODH (0.60) DHODHALDH1A1HSD17B10HIF1APTGES
SCHEMBL23590235 0.82 DHODH (0.51) DHODHALDH1A1HSD17B10HIF1APTGES
SCHEMBL23590240 0.82 DHODH (0.73) DHODHALDH1A1HSD17B10HIF1APTGES
SCHEMBL23590029 0.82 DHODH (0.58) DHODHALDH1A1HSD17B10HIF1APTGES
SCHEMBL31490582 0.81 DHODH (0.80) DHODHALDH1A1HSD17B10HIF1APTGES

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT OHIO STATE INNOVATION FOUNDATION (US) 2023-09-28 — — US disclosed
WO-2023278778-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD47-SIRPΑ THERAPEUTIC AGENT OHIO STATE INNOVATION FOUNDATION (US) 2023-01-05 — — WO disclosed
US-11312686-B2 Methods and compositions for inhibition of dihydroorotate dehydrogenase OHIO STATE INNOVATION FOUNDATION (US) 2022-04-26 — — US disclosed
US-20220064119-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE HENDRIX COLLEGE 2022-03-03 — — US disclosed
US-20210253531-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE OHIO STATE INNOVATION FOUNDATION 2021-08-19 — — US disclosed
WO-2021134045-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT OHIO STATE INNOVATION FOUNDATION (US) 2021-07-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11312686-B2 Methods and compositions for inhibition of dihydroorotate dehydrogenase DHODH, DLD, DPYD DHODH 1/4885ALDH1A1 72/4885HSD17B10 165/4885
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT DHODH, CD38, DPYD DHODH 1/4885ALDH1A1 88/4885HSD17B10 130/4885
US-20220064119-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE DHODH, DLD, DPYD DHODH 1/4885ALDH1A1 64/4885HSD17B10 172/4885
US-20210253531-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE DHODH, DLD, DPYD DHODH 1/4885ALDH1A1 72/4885HSD17B10 165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback